A phase IIb trial, multicenter, randomized, double-blind, placebo-controlled study of the safety, tolerability and efficacy…
Robin Veerman10 December 2020
A phase II / III, multicenter, randomized, double-blind controlled trial. The aim is to learn…
Robin Veerman8 December 2020
A phase IIb / III, double-blind, randomized, placebo-controlled study on the safety and effectiveness of…
Robin Veerman7 December 2020
Phase Ib / IIa, multicentre, randomized, double-blind, placebo-controlled study. The study examines the safety, tolerability,…
Robin Veerman6 December 2020
Phase II study, single center, randomized, double blind, placebo controlled. The study will investigate the…
Robin Veerman5 December 2020
Phase II / III, randomized, double-blind, placebo-controlled study. With this study, the researchers want to…
Robin Veerman4 December 2020
Phase II trial, multicenter, randomized, double-blind, placebo-controlled. The research drug T-817MA is a new drug…
Robin Veerman3 December 2020
Phase III, multicenter, randomized, double-blind, placebo-controlled study. The research drug Gantenerumab is a new drug…
Robin Veerman2 December 2020
The research drug ISIS 814907 is a new drug that is being developed against Alzheimer's…
Robin Veerman1 December 2020
